Non-invasive biomarkers or liquid biopsies have the potential to revolutionise cancer patient
management as repeated sampling allows real-time monitoring of disease progression and …

Pancreatic cancer remains difficult to treat and has a high mortality rate. It is difficult to
diagnose early, mainly due to the lack of screening imaging modalities and specific …

Despite its early promise as a diagnostic and prognostic tool, gene expression profiling
remains cost-prohibitive and challenging to implement in a clinical setting. Here, we …

Purpose A novel folate receptor-targeted β-cyclodextrin (β-CD) drug delivery vehicle was
constructed to improve the bioavailability, biosafety, and drug loading capacity of curcumin …

Hepatocellular carcinoma (HCC), with its high incidence and mortality rate, is one of the
most common malignant tumors. Despite recent development of a diagnostic and treatment …

The presence of small amounts of circulating nucleic acids in plasma and serum (CNAPS) is
not a new finding. The verification that such amounts are significantly increased in cancer …

Despite recent advances in surgical techniques and perioperative management, the
prognosis of pancreatic cancer (PCa) remains extremely poor. To provide optimal treatment …

Background Serum prostate-specific antigen (PSA) is the most widely used marker for
diagnosing prostate cancer (PCa). It lacks specificity and predictive value, resulting in …

Purpose: Colorectal cancer (CRC) is one of the most common cancers in western countries.
Identification of circulating markers for CRC would optimize early stage diagnosis and the …

To improve the clinical outcomes of cancer patients, early detection and accurate monitoring
of diseases are necessary. Numerous genetic and epigenetic alterations contribute to …